Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 is shown, and several key study documents and contact/resources have been redacted or removed from the Study Documents section, reducing access to the SAP, CSP, and related materials.
    Difference
    17%
    Check dated 2026-09-21T22:25:52.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 52621 was added as a study site. Qiryat Krinitzi, Israel, 52621 was removed from the participating locations.
    Difference
    0.0%
    Check dated 2026-09-14T20:06:45.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The study locations were updated by adding Qiryat Krinitzi, Israel, 52621 and removing Tel Litwinsky, Israel, 52621; the page revision was updated from v3.6.5 to v3.6.6.
    Difference
    0.0%
    Check dated 2026-08-31T18:30:07.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    An NIH grant/contract identifier was added to the study's list of Other Study ID Numbers, linking the trial to U.S. NIH funding.
    Difference
    0.0%
    Check dated 2026-08-24T20:02:14.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Added contact details for the study locator service, including an email address and phone number, to facilitate outreach and inquiries regarding the study.
    Difference
    0.0%
    Check dated 2026-08-17T16:08:00.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.6.4 to v3.6.5, signaling a newer page version. This is a metadata update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-10T14:24:48.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.